LMR Partners LLP - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 57 filers reported holding CTI BIOPHARMA CORP in Q1 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
LMR Partners LLP ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2022$336,000
+205.5%
71,918
+90.4%
0.00%
+33.3%
Q1 2021$110,000
+139.1%
37,769
-31.2%
0.00%
+50.0%
Q3 2019$46,000
-2.1%
54,9310.0%0.00%0.0%
Q2 2019$47,000–54,931–0.00%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q1 2021.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders